Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aspects of tuberous sclerosis complex (TSC) protein function in the brain.

V Ramesh1

  • 1Molecular Neurogenetics Unit, Massachusetts General Hospital, Building 149, 13th Street, Charlestown, MA 02129, USA. ramesh@helix.mgh.harvard.edu

Biochemical Society Transactions
|May 30, 2003
PubMed
Summary

Tuberous sclerosis complex (TSC) hamartomas may not require loss of the wild-type TSC1 or TSC2 allele for tumor development. Alternative mechanisms likely contribute to tumorigenesis in TSC central nervous system lesions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Visual Dermatology: Adult Onset Orbital Xanthogranuloma.

Journal of cutaneous medicine and surgery·2020
Same author

Epidemiology and Antifungal Susceptibility of Infections Caused by <i>Trichosporon</i> Species: An Emerging Non-<i>Candida</i> and Non-<i>Cryptococcus</i> Yeast Worldwide.

Indian journal of medical microbiology·2020
Same author

To be or not to be an oral pathologist.

Journal of oral and maxillofacial pathology : JOMFP·2020
Same author

Assessing the Efficacy and Safety of Liposomal Amphotericin B and Miltefosine in Combination for Treatment of Post Kala-Azar Dermal Leishmaniasis.

The Journal of infectious diseases·2019
Same author

Epidemiological profile and spectrum of neglected tropical disease eumycetoma from Delhi, North India.

Epidemiology and infection·2019
Same author

A distinct double positive IL-17A<sup>+</sup>/F<sup>+</sup> T helper 17 cells induced inflammation leads to IL17 producing neutrophils in Type 1 reaction of leprosy patients.

Cytokine·2019

Area of Science:

  • Genetics
  • Oncology
  • Neuroscience

Background:

  • Tuberous sclerosis complex (TSC) is an autosomal dominant disorder caused by mutations in TSC1 or TSC2.
  • TSC is characterized by hamartoma formation in multiple organs.
  • Loss of heterozygosity (LOH) is a known mechanism in TSC hamartomas, supporting a tumor-suppressor model.

Purpose of the Study:

  • To investigate the occurrence of second-hit mutations (LOH) in TSC-associated hamartomas, particularly in central nervous system (CNS) lesions.
  • To explore alternative mechanisms of tumorigenesis in TSC if LOH is not consistently observed.

Main Methods:

  • Analysis of 24 hamartomas from 10 TSC patients.
  • Utilized several methods to detect second-hit mutations in TSC1 and TSC2.
  • Investigated protein interactions of hamartin and tuberin.

Related Experiment Videos

Main Results:

  • No evidence of second-allele inactivation (LOH) was found in many CNS lesions, even in clonally derived tumors.
  • LOH is documented in renal angiomyolipomas but appears uncommon in cortical tubers.
  • Hamartin interacts with neurofilament light chain (NF-L) and ERM proteins, suggesting cytoskeletal integration.
  • Tuberin binds with Pam, a c-Myc-associated protein enriched in the brain.

Conclusions:

  • Somatic mutations leading to wild-type allele loss may not be essential for tumorigenesis in all TSC hamartoma types.
  • Alternative molecular mechanisms likely drive tumor formation in some TSC lesions.
  • The tuberin-hamartin complex may possess distinct functions within the CNS, potentially involving cytoskeletal regulation and interaction with oncogenic pathways.